In addition, it is worth further exploring the beneficial effects of NLRP3 deactivators (Table 1) on adipose tissue inflammation and metabolic health during aging and obesity, yet their potential side effects on immunosuppression should also be considered. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.